Biotechnology - Mergers & Acquisitions, Novartis

Filter

Popular Filters

Novartis to acquire CoStim, expanding cancer immunotherapy research program

Novartis to acquire CoStim, expanding cancer immunotherapy research program

17-02-2014

Swiss drug major Novartis said this morning that it is broadening its cancer immunotherapy research program…

BiotechnologyCoStim PharmaceuticalsMergers & AcquisitionsNovartisOncology

Company Spotlight

ImmunoGen

ImmunoGen

Back to top